A pioneer in biologics solutions, Biomatlante develops, manufactures and commercializes synthetic bone graft technologies.
Biomatlante specializes in producing synthetic biomaterials for bone regeneration and is a world leader in bone graft technologies, selling its products in over 50 countries. Biomatlante’s products are routinely used in orthopaedics and trauma surgery, in spine, ENT, stomatology and dental surgery.
Our global process integrates a strategy of strong innovation and aggressive product development required to meet and exceed the needs of today’s market.
Our R&D collaborates very closely with universities and research centers across the world: Amongst others, we have developed partnerships with CNRS (French National Center For Scientific Research), INSERM (National Institute of Health and Medical Research) as well as with several national and international universities. These partnerships augment our competence in innovation, technological transfers of new biomaterials, new surgical technologies and provide the necessary intellectual protection required to foster long-term projects.